Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.
Clinical trial NCT07363304 · RECRUITING
Trial details
- NCT number
- NCT07363304
- Sponsor
- Meyer Children's Hospital IRCCS
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-02
- Primary completion
- 2028-11-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.